57 is the total number of securities CHI Advisors LLC has owned. The longest CHI Advisors LLC has owned a single stock is 17 quarters.
Period | Weighting | Quarter | |||||||
---|---|---|---|---|---|---|---|---|---|
Ticker | Name | Longest | Shortest | Min. | Avg. | Max. | First | Latest | ↓ Count |
DTIL | PRECISION BIOSCIENCES INC | 17 | 17 | 0.08% | 3.05% | 13.37% | Q3 2019 | Q3 2023 | 17 |
OVID | OVID THERAPEUTICS INC | 17 | 17 | 0.20% | 1.21% | 5.82% | Q3 2019 | Q3 2023 | 17 |
CRVS | CORVUS PHARMACEUTICALS... | 16 | 16 | 0.14% | 0.71% | 1.81% | Q3 2019 | Q2 2023 | 16 |
KZR | KEZAR LIFE SCIENCES INC | 15 | 15 | 0.18% | 1.69% | 5.81% | Q3 2019 | Q1 2023 | 15 |
PLRX | PLIANT THERAPEUTICS INC | 14 | 14 | 7.92% | 16.66% | 29.21% | Q2 2020 | Q3 2023 | 14 |
RPTX | REPARE THERAPEUTICS INC | 14 | 14 | 7.83% | 16.54% | 30.30% | Q2 2020 | Q3 2023 | 14 |
ORTX | ORCHARD THERAPEUTICS PLC | 14 | 14 | 0.79% | 10.92% | 52.57% | Q3 2019 | Q4 2022 | 14 |
LRMR | LARIMAR THERAPEUTICS INC | 14 | 14 | 1.13% | 4.65% | 9.14% | Q2 2020 | Q3 2023 | 14 |
KROS | KEROS THERAPEUTICS INC | 14 | 14 | 0.15% | 3.70% | 8.62% | Q2 2020 | Q3 2023 | 14 |
INZY | INOZYME PHARMA INC | 13 | 13 | 0.62% | 3.17% | 9.44% | Q3 2020 | Q3 2023 | 13 |
CGEM | CULLINAN ONCOLOGY INC | 11 | 11 | 9.10% | 12.68% | 18.37% | Q1 2021 | Q3 2023 | 11 |
FRLN | FREELINE THERAPEUTICS ... | 11 | 11 | 0.57% | 2.64% | 7.35% | Q3 2020 | Q1 2023 | 11 |
IKNA | IKENA ONCOLOGY INC | 11 | 11 | 1.16% | 2.51% | 4.61% | Q1 2021 | Q3 2023 | 11 |
GTHX | G1 THERAPEUTICS INC | 11 | 11 | 0.20% | 0.65% | 1.58% | Q2 2020 | Q4 2022 | 11 |
ONCR | ONCORUS INC | 10 | 10 | 0.16% | 3.82% | 15.30% | Q4 2020 | Q1 2023 | 10 |
AKUS | AKOUOS INC | 10 | 10 | 1.50% | 3.60% | 8.56% | Q2 2020 | Q3 2022 | 10 |
RXDX | PROMETHEUS BIOSCIENCES... | 9 | 9 | 10.51% | 21.35% | 27.06% | Q1 2021 | Q1 2023 | 9 |
VECT | VECTIVBIO HLDG AG | 9 | 9 | 4.36% | 8.52% | 14.24% | Q2 2021 | Q2 2023 | 9 |
OMEGA THERAPEUTICS INC | 9 | 9 | 0.90% | 2.40% | 5.81% | Q3 2021 | Q3 2023 | 9 | |
RARE | ULTRAGENYX PHARMACEUTI... | 7 | 2 | 0.05% | 1.26% | 4.12% | Q3 2019 | Q3 2023 | 9 |
CMPX | COMPASS THERAPEUTICS INC | 8 | 8 | 1.65% | 2.58% | 3.79% | Q4 2021 | Q3 2023 | 8 |
BPMC | BLUEPRINT MEDICINES CORP | 7 | 1 | 0.07% | 1.31% | 4.96% | Q3 2019 | Q3 2023 | 8 |
2SEVENTY BIO INC | 7 | 7 | 0.83% | 2.78% | 5.95% | Q1 2022 | Q3 2023 | 7 | |
GBT | GLOBAL BLOOD THERAPEUT... | 7 | 7 | 0.12% | 0.78% | 1.90% | Q3 2019 | Q1 2021 | 7 |
BLUE | BLUEBIRD BIO INC | 6 | 6 | 0.10% | 0.45% | 1.07% | Q3 2019 | Q4 2020 | 6 |
LVGO | LIVONGO HEALTH INC | 5 | 5 | 0.18% | 20.26% | 49.84% | Q3 2019 | Q3 2020 | 5 |
RALLYBIO CORP | 5 | 5 | 0.52% | 0.93% | 1.27% | Q3 2022 | Q3 2023 | 5 | |
MYOK | MYOKARDIA INC | 5 | 5 | 0.34% | 0.84% | 1.66% | Q3 2019 | Q3 2020 | 5 |
ADVM | ADVERUM BIOTECHNOLOGIE... | 5 | 5 | 0.08% | 0.48% | 1.47% | Q1 2020 | Q1 2021 | 5 |
LABD | DIREXION SHS ETF TR | 2 | 2 | 0.12% | 0.92% | 1.84% | Q3 2022 | Q3 2023 | 4 |
UMRX | UNUM THERAPEUTICS INC | 4 | 4 | 0.17% | 0.68% | 1.11% | Q3 2019 | Q2 2020 | 4 |
ORCHARD THERAPEUTICS PLC | 3 | 3 | 1.12% | 2.63% | 5.56% | Q1 2023 | Q3 2023 | 3 | |
SYROS PHARMACEUTICALS INC | 3 | 3 | 0.54% | 1.10% | 2.03% | Q1 2023 | Q3 2023 | 3 | |
XBI | SPDR SER TR | 2 | 1 | 0.02% | 0.08% | 0.14% | Q4 2020 | Q2 2022 | 3 |
PLRX | PLIANT THERAPEUTICS INC | 2 | 1 | 0.01% | 0.03% | 0.05% | Q4 2022 | Q3 2023 | 3 |
ACELYRIN INC | 2 | 2 | 9.12% | 13.01% | 16.89% | Q2 2023 | Q3 2023 | 2 | |
AMWL | AMERICAN WELL CORP | 2 | 2 | 1.77% | 2.20% | 2.62% | Q3 2020 | Q4 2020 | 2 |
DISC MEDICINE INC | 2 | 2 | 0.47% | 1.08% | 1.69% | Q2 2023 | Q3 2023 | 2 | |
NKTX | NKARTA INC | 2 | 2 | 0.42% | 1.05% | 1.68% | Q2 2022 | Q3 2022 | 2 |
BDTX | BLACK DIAMOND THERAPEU... | 2 | 2 | 0.82% | 0.98% | 1.15% | Q2 2023 | Q3 2023 | 2 |
EIGR | EIGER BIOPHARMACEUTICA... | 2 | 2 | 0.46% | 0.69% | 0.92% | Q2 2022 | Q3 2022 | 2 |
ENTRADA THERAPEUTICS INC | 1 | 1 | 0.22% | 0.49% | 0.76% | Q2 2022 | Q1 2023 | 2 | |
GRPH | GRAPHITE BIO INC | 2 | 2 | 0.18% | 0.20% | 0.23% | Q2 2023 | Q3 2023 | 2 |
FREELINE THERAPEUTICS ... | 2 | 2 | 0.02% | 0.08% | 0.15% | Q2 2023 | Q3 2023 | 2 | |
GBT | GLOBAL BLOOD THERAPEUT... | 2 | 2 | 0.00% | 0.01% | 0.01% | Q3 2020 | Q4 2020 | 2 |
MINERALYS THERAPEUTICS... | 1 | 1 | 2.14% | 2.14% | 2.14% | Q3 2023 | Q3 2023 | 1 | |
MOONLAKE IMMUNOTHERAPE... | 1 | 1 | 1.36% | 1.36% | 1.36% | Q3 2023 | Q3 2023 | 1 | |
SAGIMET BIOSCIENCES INC | 1 | 1 | 1.22% | 1.22% | 1.22% | Q3 2023 | Q3 2023 | 1 | |
BOLD | AUDENTES THERAPEUTICS INC | 1 | 1 | 0.96% | 0.96% | 0.96% | Q3 2019 | Q3 2019 | 1 |
KDNY | CHINOOK THERAPEUTICS INC | 1 | 1 | 0.83% | 0.83% | 0.83% | Q1 2023 | Q1 2023 | 1 |
HOOK | HOOKIPA PHARMA INC | 1 | 1 | 0.21% | 0.21% | 0.21% | Q2 2023 | Q2 2023 | 1 |
PHAS | PHASEBIO PHARMACEUTICA... | 1 | 1 | 0.17% | 0.17% | 0.17% | Q2 2022 | Q2 2022 | 1 |
RPTX | REPARE THERAPEUTICS INC | 1 | 1 | 0.06% | 0.06% | 0.06% | Q3 2023 | Q3 2023 | 1 |
RXDX | PROMETHEUS BIOSCIENCES... | 1 | 1 | 0.03% | 0.03% | 0.03% | Q1 2023 | Q1 2023 | 1 |
KZR | KEZAR LIFE SCIENCES INC | 1 | 1 | 0.00% | 0.00% | 0.00% | Q2 2022 | Q2 2022 | 1 |
DTIL | PRECISION BIOSCIENCES INC | 1 | 1 | 0.00% | 0.00% | 0.00% | Q4 2020 | Q4 2020 | 1 |
EIGR | EIGER BIOPHARMACEUTICA... | 1 | 1 | 0.00% | 0.00% | 0.00% | Q2 2022 | Q2 2022 | 1 |
Download |
The securities at the top of the list , including PRECISION BIOSCIENCES INC, OVID THERAPEUTICS INC, and CORVUS PHARMACEUTICALS INC, are the highest-conviction holdings of CHI Advisors LLC.
The conviction is calculated by counting the number of quarters a security has been reported by CHI Advisors LLC. The higher the number, the higher the conviction and longer the holding period.
This page lists all the securities that CHI Advisors LLC owns currently or has owned in the past.